{"organizations": [], "uuid": "d85c4a0ac3a901dbdd82dd8ca6e6a3bb9a315250", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000551/device/rss", "section_title": "California", "url": "https://www.cnbc.com/2018/05/11/the-associated-press-eiger-biopharma-1q-earnings-snapshot.html", "country": "US", "domain_rank": 767, "title": "Eiger BioPharma: 1Q Earnings Snapshot", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-11T16:09:00.000+03:00", "replies_count": 0, "uuid": "d85c4a0ac3a901dbdd82dd8ca6e6a3bb9a315250"}, "author": "cnbc.com", "url": "https://www.cnbc.com/2018/05/11/the-associated-press-eiger-biopharma-1q-earnings-snapshot.html", "ord_in_thread": 0, "title": "Eiger BioPharma: 1Q Earnings Snapshot", "locations": [], "entities": {"persons": [], "locations": [{"name": "palo alto", "sentiment": "none"}, {"name": "calif.", "sentiment": "none"}, {"name": "palo alto", "sentiment": "none"}], "organizations": [{"name": "eigr", "sentiment": "negative"}, {"name": "eiger biopharmaceuticals inc.", "sentiment": "negative"}, {"name": "ap", "sentiment": "negative"}, {"name": "zacks investment research", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "PALO ALTO, Calif. (AP) _ Eiger BioPharmaceuticals Inc. (EIGR) on Friday reported a loss of $8.8 million in its first quarter.\nThe Palo Alto, California-based company said it had a loss of 84 cents per share.\nThe results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of $1.01 per share.\nEiger BioPharma shares have dropped 34 percent since the beginning of the year. The stock has increased 21 percent in the last 12 months.\nThis story was generated by Automated Insights ( http://automatedinsights.com/ap ) using data from Zacks Investment Research. Access a Zacks stock report on EIGR at https://www.zacks.com/ap/EIGR", "external_links": ["https://www.zacks.com/ap/EIGR", "http://automatedinsights.com/ap"], "published": "2018-05-11T16:09:00.000+03:00", "crawled": "2018-05-11T22:06:40.006+03:00", "highlightTitle": ""}